Title : The systemic treatment of recurrent ovarian cancer revisited.

Pub. Date : 2021 Jun

PMID : 33675937






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 For patients with recurrent high grade ovarian cancer, which responds to platinum-based treatment maintenance therapy with a poly(ADP-ribose) polymerase (PARP) inhibitor can be offered, regardless of BRCA mutation status. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens
2 For patients with recurrent high grade ovarian cancer, which responds to platinum-based treatment maintenance therapy with a poly(ADP-ribose) polymerase (PARP) inhibitor can be offered, regardless of BRCA mutation status. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens